Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.86B |
| 2 |
Apple
AAPL
|
+$2.18B |
| 3 |
Microsoft
MSFT
|
+$1.47B |
| 4 |
Amazon
AMZN
|
+$943M |
| 5 |
Alibaba
BABA
|
+$864M |
Top Sells
| 1 |
Keurig Dr Pepper
KDP
|
+$187M |
| 2 |
BFT.U
Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an
BFT.U
|
+$178M |
| 3 |
NIO
NIO
|
+$156M |
| 4 |
Oracle
ORCL
|
+$151M |
| 5 |
PayPal
PYPL
|
+$148M |
Sector Composition
| 1 | Technology | 18.9% |
| 2 | Consumer Discretionary | 12.17% |
| 3 | Healthcare | 12.05% |
| 4 | Financials | 9.25% |
| 5 | Industrials | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Genesco
GCO
$364M
| $826K | ﹤0.01% |
27,463
-89,469
| -77% | -$2.69M |
|
2927
Flowers Foods
FLO
$2.88B
| $824K | ﹤0.01% |
36,407
+13,924
| +62% | +$315K |
|
2928
Synovus
SNV
$7.02B
| $823K | ﹤0.01% |
25,415
-62,993
| -71% | -$2.04M |
|
2929
Revolve Group
RVLV
$1.69B
| $822K | ﹤0.01% |
26,385
-250,725
| -90% | -$7.81M |
|
2930
CB Financial Services
CBFV
$160M
| $821K | ﹤0.01% |
41,050
-13,108
| -24% | -$262K |
|
|
RPAI
2931
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $821K | ﹤0.01% |
95,867
+79,427
| +483% | +$680K |
|
2932
iShares 10-20 Year Treasury Bond ETF
TLH
$11.6B
| $820K | ﹤0.01% |
5,151
+840
| +19% | +$134K |
|
|
GLOP
2933
DELISTED
GASLOG PARTNERS LP
GLOP
| $819K | ﹤0.01% |
300,943
+270,996
| +905% | +$738K |
|
2934
TruBridge
TBRG
$302M
| $818K | ﹤0.01% |
+30,488
| New | +$818K |
|
|
CHUY
2935
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $811K | ﹤0.01% |
30,632
-32,560
| -52% | -$862K |
|
2936
American Superconductor
AMSC
$2.5B
| $810K | ﹤0.01% |
+34,582
| New | +$810K |
|
2937
ARK Fintech Innovation ETF
ARKF
$1.38B
| $810K | ﹤0.01% |
16,287
+8,407
| +107% | +$418K |
|
2938
Dyne Therapeutics
DYN
$1.82B
| $810K | ﹤0.01% |
38,590
-155,475
| -80% | -$3.26M |
|
2939
Carlyle Secured Lending
CGBD
$984M
| $809K | ﹤0.01% |
+78,889
| New | +$809K |
|
2940
Carlisle Companies
CSL
$15.3B
| $808K | ﹤0.01% |
5,172
-98,917
| -95% | -$15.5M |
|
2941
TETRA Technologies
TTI
$652M
| $807K | ﹤0.01% |
937,237
-1,069,476
| -53% | -$921K |
|
2942
Copel
ELP
$7.08B
| $806K | ﹤0.01% |
+140,868
| New | +$806K |
|
|
SHSP
2943
DELISTED
SharpSpring, Inc.
SHSP
| $806K | ﹤0.01% |
49,539
+32,118
| +184% | +$523K |
|
2944
Kimball Electronics
KE
$753M
| $802K | ﹤0.01% |
50,151
-33,686
| -40% | -$539K |
|
2945
Vital Energy
VTLE
$623M
| $801K | ﹤0.01% |
40,649
-81,692
| -67% | -$1.61M |
|
|
TBCH
2946
Turtle Beach Corporation Common Stock
TBCH
$303M
| $801K | ﹤0.01% |
37,190
-72,006
| -66% | -$1.55M |
|
2947
Relmada Therapeutics
RLMD
$51.4M
| $800K | ﹤0.01% |
+24,930
| New | +$800K |
|
2948
First Interstate BancSystem
FIBK
$3.41B
| $797K | ﹤0.01% |
19,538
+5,340
| +38% | +$218K |
|
|
MBT
2949
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $796K | ﹤0.01% |
88,984
-897,613
| -91% | -$8.03M |
|
2950
Larimar Therapeutics
LRMR
$334M
| $789K | ﹤0.01% |
36,862
-7,024
| -16% | -$150K |
|